Conjunctival Goblet Cell Mucin Secretion in Inflammation and Its Resolution
炎症中结膜杯状细胞粘蛋白的分泌及其解决
基本信息
- 批准号:8268449
- 负责人:
- 金额:$ 45.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAllergensAllergicAllergic ConjunctivitisAllergic inflammationAnti-Inflammatory AgentsAnti-inflammatoryAttenuatedBiological AssayCD59 AntigenCarbacholCell Culture TechniquesCell secretionCell surfaceCellsCholinergic AgonistsChronicCyclic AMPDiseaseEnvironmentEnzyme-Linked Immunosorbent AssayEyeFeelingFilmFluorescence MicroscopyGoalsGoblet CellsHistamineHistamine H1 ReceptorsHistamine H3 AgonistHistamine ReceptorHistamine ReleaseHumanHypersensitivityIndividualInflammationInflammation MediatorsInflammatoryInflammatory ResponseInjuryInvadedKeratoconjunctivitisLaboratoriesLeukocytesLeukotriene B4Leukotriene C4Leukotriene D4Leukotriene ProductionLeukotrienesLipoxinsLymphocyteMAP Kinase GeneMeasuresMediator of activation proteinModelingMucinsMucous body substanceMuscarinic Acetylcholine ReceptorNerveNeurotransmittersPainProcessProductionRattusReceptor SignalingRecruitment ActivityReflex actionResolutionSignal PathwaySignal TransductionSignaling ProteinSiteSquamous CellStevens-Johnson SyndromeTimeVernal KeratoconjunctivitisWestern Blottingafferent nerveconjunctivaeye drynessinsightirritationmast cellmicrobialmicroorganismneurotransmitter releaseneutrophilnovelocular surfacereceptorrelating to nervous systemresponse
项目摘要
Project Summary
Depletion of filled (mucin-containing) goblet cells is a hallmark of diseases of ocular surface inflammation and
allergic inflammation such as dry eye and most forms of allergic conjunctivitis. Goblet cell mucins protect the
ocular surface from the external environment and loss of filled goblet cells is deleterious to the ocular surface.
This loss indicates that goblet cells have secreted and not been able to resynthesize mucins, perhaps because
of chronic stimulation. The chronic stimulation could arise from mediators of conjunctival inflammation, such as
leukotrienes and histamine, stimulating goblet cell secretion. In addition, activation of sensory nerves by
inflammatory mediators could activate a neural reflex arc causing secretion. Termination of inflammation
(resolution) is an active process producing molecules such as the resolvins that decrease inflammatory-
mediator stimulated goblet cell secretion, allowing goblet cells to refill. The overall goal of this project is to
determine the cellular mechanisms by which pro-inflammatory mediators induce goblet cell secretion and anti-
inflammatory, proresolution compounds attenuate goblet cell secretion to restore the normal, critical mucin
layer to the ocular surface. We hypothesize that in the inflamed conjunctiva: 1. Histamine and the leukotrienes
LTC4 and LTD4 produced by activated mast cells and LTB4 released from invading neutrophils cause goblet
cell mucin secretion by activating specific receptors and signaling pathways, 2: Activation of sensory nerves by
a reflex arc stimulates parasympathetic nerves to release neurotransmitters that stimulate goblet cell secretion,
and 3. Goblet cell secretion is terminated by production of resolvins that inhibit histamine-, leukotriene- and
cholinergic agonist-stimulated goblet cell secretion by blocking specific steps in the signaling pathways. We
plan to address the following: 1. Specific Aim 1: Does histamine stimulate cultured conjunctival goblet cells to
secrete mucin and which histamine receptors and cellular signaling pathways are activated? 2. Specific Aim 2:
Do the leukotrienes LTC4, LTD4, and LTB4 stimulate cultured conjunctival goblet cells to secrete mucins and
which specific receptors and signaling pathways are induced? and 3. Specific Aim 3: Do the resolvins RvE1
and RvD1 inhibit cultured conjunctival goblet cell secretion stimulated by histamine, leukotrienes, and
cholinergic agonists and what are the cellular mechanisms inhibited. Goblet cells cultured from rat and human
conjunctiva will be used. Mucin secretion will be measured by a modified ELISA assay. Intracellular [Ca2+] will
be investigated in single cells by fluorescence microscopy. Phosphorylated cellular signaling proteins will be
measured by western blotting analysis. Receptor specific agonists and antagonists will be used to unravel
signaling pathways. Production of resolvins and other pro-resolution compounds will be measured by lipidomic
analysis.
项目摘要
充满的(含粘蛋白的)杯状细胞枯竭是眼表炎症和眼球疾病的一个标志。
过敏性炎症,如干眼和大多数形式的过敏性结膜炎。杯状细胞粘蛋白保护
眼表不受外界环境的影响,杯状细胞的充盈丢失对眼表是有害的。
这种丢失表明杯状细胞已经分泌,不能重新合成粘蛋白,可能是因为
是一种慢性刺激。慢性刺激可能来自结膜炎症介质,如
白三烯和组胺,刺激杯状细胞分泌。此外,感觉神经的激活通过
炎症介质可以激活神经反射弧,导致分泌物。消炎止痛
(分解)是一个产生分子的活跃过程,例如减少炎症的分解素。
中介物刺激杯状细胞分泌,使杯状细胞重新充盈。这个项目的总体目标是
确定促炎介质诱导杯状细胞分泌和抗炎的细胞机制
炎性亲和化合物减弱杯状细胞分泌以恢复正常的临界粘蛋白
层到眼球表面。我们推测在炎症的结膜中:1.组胺和白三烯
活化的肥大细胞产生的LTC4和LTD4以及入侵的中性粒细胞释放的LTB4导致杯状
激活特定受体和信号通路的细胞粘蛋白分泌,2:通过激活感觉神经
反射弧刺激副交感神经释放神经递质,刺激杯状细胞分泌,
3.杯状细胞分泌被抑制组胺、白三烯和
胆碱能激动剂通过阻断信号通路中的特定步骤刺激杯状细胞的分泌。我们
计划解决以下问题:1.具体目标1:组胺是否刺激培养的结膜杯状细胞
分泌粘蛋白和哪些组胺受体和细胞信号通路被激活?2.特定目标2:
白三烯LTC4、LTD4和LTB4是否刺激培养的结膜杯状细胞分泌粘蛋白和
诱导了哪些特定的受体和信号通路?3.具体目标3:做好RvE1
和RvD1抑制组胺、白三烯刺激的结膜杯状细胞分泌。
胆碱能激动剂及其抑制的细胞机制。大鼠和人培养的杯状细胞
将使用结膜。粘蛋白的分泌量将用一种改良的酶联免疫吸附试验测定。细胞内[Ca2+]将
在单细胞中用荧光显微镜观察。磷酸化的细胞信号蛋白将是
经免疫印迹分析检测。受体特异性激动剂和拮抗剂将被用来解开
信号通路。拆分药物和其他有利于拆分的化合物的生产将通过脂组分进行测量
分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Darlene A Dartt其他文献
Darlene A Dartt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Darlene A Dartt', 18)}}的其他基金
Mechanisms underlying mustard gas-induced conjunctival injury and use of lipid mediators as medical countermeasures
芥子气引起的结膜损伤的机制以及脂质介质作为医疗对策的使用
- 批准号:
10882060 - 财政年份:2023
- 资助金额:
$ 45.85万 - 项目类别:
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
10338062 - 财政年份:2020
- 资助金额:
$ 45.85万 - 项目类别:
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
10557095 - 财政年份:2020
- 资助金额:
$ 45.85万 - 项目类别:
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
10089447 - 财政年份:2020
- 资助金额:
$ 45.85万 - 项目类别:
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
9884619 - 财政年份:2020
- 资助金额:
$ 45.85万 - 项目类别:
Conjunctival Goblet Cell Mucin Secretion in Inflammation and Its Resolution
炎症中结膜杯状细胞粘蛋白的分泌及其解决
- 批准号:
9920424 - 财政年份:2019
- 资助金额:
$ 45.85万 - 项目类别:
Conjunctival Goblet Cell NLRP3 Inflammasome in Ocular Surface Bacterial Infection
眼表细菌感染中的结膜杯状细胞NLRP3炎症小体
- 批准号:
8461558 - 财政年份:2012
- 资助金额:
$ 45.85万 - 项目类别:
Conjunctival Goblet Cell NLRP3 Inflammasome in Ocular Surface Bacterial Infection
眼表细菌感染中的结膜杯状细胞NLRP3炎症小体
- 批准号:
8274619 - 财政年份:2012
- 资助金额:
$ 45.85万 - 项目类别:
Conjunctival Goblet Cell NLRP3 Inflammasome in Ocular Surface Bacterial Infection
眼表细菌感染中的结膜杯状细胞NLRP3炎症小体
- 批准号:
8663916 - 财政年份:2012
- 资助金额:
$ 45.85万 - 项目类别:
Lacrimal Gland Regeneration:Identification and Isolation of Progenitor Cells
泪腺再生:祖细胞的鉴定和分离
- 批准号:
7978066 - 财政年份:2010
- 资助金额:
$ 45.85万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 45.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 45.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 45.85万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 45.85万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 45.85万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 45.85万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 45.85万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 45.85万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 45.85万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 45.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)